Empagliflozin in women with type 2 diabetes and cardiovascular disease – An analysis of EMPA-REG OUTCOME
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Jun 07, 2018
Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study
Journal of the American Academy of Dermatology | Jun 07, 2018
Most read this week